bluebird bio, Inc. Proceeds from Other Debt
bluebird bio, Inc. reported Proceeds from Other Debt of $54.73 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherDebt · last filed 2025-05-14
- bluebird bio, Inc. proceeds from other debt for the quarter ending 2025-03-31 was $54.73M, a 261.96% increase year-over-year.
- bluebird bio, Inc. proceeds from other debt for the quarter ending 2024-12-31 was $51.36M, a 1938.25% increase year-over-year.
- bluebird bio, Inc. proceeds from other debt for the quarter ending 2024-09-30 was $14.83M.
- bluebird bio, Inc. proceeds from other debt for the quarter ending 2024-06-30 was $20.70M.
- bluebird bio, Inc. proceeds from other debt for fiscal 2024 was $102.01M, a 3948.02% increase from fiscal 2023.
- bluebird bio, Inc. proceeds from other debt for fiscal 2023 was $2.52M.
- bluebird bio, Inc. proceeds from other debt for fiscal 2022 was $0.00.
| Period end | Proceeds from Other Debt 3 month | Proceeds from Other Debt 6 month | Proceeds from Other Debt 9 month | Proceeds from Other Debt 12 month |
|---|---|---|---|---|
| 2025-03-31 | $54.73M 10-Q · filed 2025-05-14 | $106.09M derived: sum of 2 quarters · filed 2025-05-14 | $120.92M derived: sum of 3 quarters · filed 2025-05-14 | $141.62M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | $51.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $66.19M derived: sum of 2 quarters · filed 2025-03-27 | $86.89M derived: sum of 3 quarters · filed 2025-03-27 | $102.01M 10-K · filed 2025-03-27 |
| 2024-09-30 | $14.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $35.53M derived: sum of 2 quarters · filed 2024-11-14 | $50.65M 10-Q · filed 2024-11-14 | $53.17M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | $20.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-27 | $35.82M 10-Q · filed 2024-09-27 | $38.34M derived: sum of 3 quarters · filed 2025-05-14 | $38.34M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | $15.12M 10-Q · filed 2025-05-14 | $17.64M derived: sum of 2 quarters · filed 2025-05-14 | $17.64M derived: sum of 3 quarters · filed 2025-05-14 | $17.64M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.52M derived: sum of 2 quarters · filed 2025-03-27 | $2.52M derived: sum of 3 quarters · filed 2025-03-27 | $2.52M 10-K · filed 2025-03-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-27 | $0.00 10-Q · filed 2024-09-27 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-09-13 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-09-13 |